Nephros (NEPH) Shares Outstanding (2010 - 2026)

Nephros' Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $10.8 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 2.29% year-over-year to $10.8 million in Q1 2026; TTM through Mar 2026 was $10.8 million, a 2.29% increase from a year earlier, with the FY2025 full-year figure at $10.6 million, up 0.94% from the prior year.
• Shares Outstanding (Entity) grew to $10.8 million in Q1 2026 per NEPH's latest filing, from $10.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $10.8 million in Q1 2026 and bottomed at $10.3 million in Q4 2022.
• The 5-year median for Shares Outstanding (Entity) is $10.5 million (2024), against an average of $10.5 million.
• Across the five-year window, Shares Outstanding (Entity) climbed 3.68% in 2022 and gained 0.01% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $10.3 million in 2022, then grew by 2.39% to $10.5 million in 2023, then gained by 0.01% to $10.5 million in 2024, then advanced by 0.94% to $10.6 million in 2025, then rose by 1.87% to $10.8 million in 2026.
• Per Business Quant, the three latest NEPH Shares Outstanding (Entity) figures stand at $10.8 million (Q1 2026), $10.6 million (Q4 2025), and $10.6 million (Q3 2025).